Episode 420 -- DOJ Announces New West Coast Health Care Fraud Strike Force
Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Health-e Law Podcast, Episode 26 Pt. 1 | AI Adoption in Healthcare: Managing Data Privacy, Vendor Relationships and Governance
False Claims Act Insights - Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
Patients Recording Medical Visits: What Health Care Providers Need to Know
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
On June 4, 2026, the United States Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. In its decision, the Supreme Court reversed the Federal Circuit, and held that Amarin’s complaint...more
The Deal - On June 2, 2026, the Federal Trade Commission (FTC) required nonprofit health system Ascension Health Alliance to divest several ambulatory surgery centers (ASCs) as a condition of closing its proposed $3.9...more
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more
The U.S. Departments of the Treasury, Labor, and Health and Human Services (the Departments), along with the U.S. Office of Personnel Management, issued a final rule on May 28, 2026, implementing several modifications to the...more
On May 28, 2026, the U.S. Department of Labor’s (DOL) Wage and Hour Division (WHD) issued a collection of opinion letters that provide guidance on several important issues under the Fair Labor Standards Act (FLSA)....more
The Supreme Court has issued a unanimous decision in Hikma v. Amarin, holding that Amarin did not meet its pleading burden of plausibly alleging that Hikma induced infringement of Amarin’s patents relating to reducing the...more
The Department of Justice (“DOJ”) continues to expand its aggressive health care fraud enforcement efforts with the announcement of a new West Coast Health Care Fraud Strike Force....more
The Supreme Court issued a unanimous decision for Hikma in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. It reversed the Federal Circuit and held that Amarin failed to state a claim that Hikma induced infringement...more
The Senate passed the reconciliation 2.0 package, which funds ICE and CBP and includes no healthcare provisions. The bill now moves to the House, though Republican leadership cancelled Friday votes, postponing further action...more
Below is a tracker of healthcare-related executive orders (EOs) issued by the Trump administration, including overviews of each EO and the date each EO was signed. We will regularly update this tracker as additional EOs are...more
On May 28, 2026, the Departments of Health and Human Services, Labor, and the Treasury finalized a rule implementing changes to the No Surprises Act's independent dispute resolution process, including new standardized...more
The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a...more
Prater named new head of FDA Human Foods Program. Donald Prater, DVM, has been appointed Acting Deputy Commissioner for Food at the United States Food and Drug Administration (FDA). He replaces Kyle Diamantas, who was named...more
The conformity assessment of AI-based medical devices (“AIMD”) raises questions for companies developing and marketing such devices. This is true in particular for AIMDs that continue to learn after being placed on the...more
The new framework includes a combined regulatory-ethics review process, expedited approval timelines, and an automatic authorisation pathway for low-risk trials, among other changes....more
On May 18, 2026, the U.S. Department of Health and Human Services (HHS) announced the restructuring of its Office for Civil Rights (OCR) enforcement efforts, establishing a dedicated unit for privacy and security enforcement...more
Over the past several years the U.S. government and many state governments have undertaken a sustained series of actions aimed at restricting the legal rights and protections of transgender and non-binary populations....more
Law No. 2026-403 of 26 May 2026 on the simplification of economic activity introduces several measures that have long been awaited by stakeholders in the healthcare sector. Against a backdrop of increasing competition among...more
The US Supreme Court’s recent decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc. clarifies what federal pleading standards demand in induced-infringement cases involving pharmaceutical “skinny” labels and...more
The Office of the Inspector General (OIG) continues to focus on Medicare Advantage (MA) risk adjustment payments, issuing a report this week detailing its audit of MA risk adjustment payments based on acute stroke diagnosis...more
The US Department of Justice’s Civil Division recently announced reforms designed to accelerate the review and enforcement of False Claims Act whistleblower matters alleging fraud against federally funded, state-administered...more
Counsel advising acquirers in pharmaceutical, biotechnology, and medical device transactions must assess a target's compliance with Food and Drug Administration (FDA) requirements in granular detail as a fundamental...more
Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889 - Introduction - Yesterday, the Supreme Court held in a unanimous 9-0 decision that induced patent infringement requires active steps to encourage...more
Key Takeaways - On June 1, CMS released an interim final rule implementing the new Medicaid community engagement requirement (i.e., work requirement) as a condition of Medicaid eligibility for adults aged 19-64 with access to...more
Since Governor Newsom signed AB 1415 into law last October, stakeholders have been awaiting the release of draft regulations from California’s Office of Health Care Affordability (“OHCA”) to clarify the statute’s notice and...more